Curis Lifescien.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1BZN01016
  • NSEID: CURIS
  • BSEID:
INR
97.00
0.00 (0.00%)
BSENSE

Mar 05

BSE+NSE Vol: 28000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 38.18% vs 0.39% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 13.71% vs 157.88% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 30.31% vs -36.07% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 25.44% vs 296.98% in Mar 2024

Compare Profit and Loss Results of Curis Lifescien.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
49.00
57.00
-8.00
-14.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
49.00
57.00
-8.00
-14.04%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-3.00
1.00
33.33%
Raw Materials Consumed
33.00
43.00
-10.00
-23.26%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
3.00
3.00
0.00
0.00%
Operating Expenses
1.00
0.00
1.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39.00
45.00
-6.00
-13.33%
Operating Profit (PBDIT) excl Other Income
9.00
11.00
-2.00
-18.18%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
10.00
11.00
-1.00
-9.09%
Interest
1.00
1.00
0.00
0.00%
Profit before Depriciation and Tax
8.00
10.00
-2.00
-20.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
8.00
9.00
-1.00
-11.11%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
9.00
-1.00
-11.11%
Provision for Tax
2.00
2.00
0.00
0.00%
Profit After Tax
6.00
6.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
5.00
1.00
4.00
400.00%
Profit Available for appropriations
11.00
8.00
3.00
37.50%
Appropriations
11.00
8.00
3.00
37.50%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.29
8.48
1.81
21.34%
Profit And Loss - Net Sales
Net Sales 49.13 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 38.18% vs 0.39% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.54 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.71% vs 157.88% in Mar 2024

Profit And Loss - Interest
Interest 1.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.31% vs -36.07% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 6.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.44% vs 296.98% in Mar 2024